{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-001296","form_type":"8-K","ticker":"VICP","cik":"0001468639","company_name":"Vicapsys Life Sciences, Inc.","filed_at":"2023-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.123533+00:00","generated_at":"2026-06-20T15:57:52.216607+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vicapsys Life Sciences enters CEO employment agreement with $250k base salary, performance-based equity","bullets":["CEO Federico Pier receives $250k annual base salary, subject to annual increase by Board.","Eligible for annual cash bonus up to 100% of base salary based on performance objectives.","One-time $100k cash bonus if common stock listed on NASDAQ/NYSE or company secures $8M+ financing.","Equity awards: 1% of fully diluted shares at $250M market cap; additional 1% at $500M market cap.","Agreement has five-year term with automatic yearly renewal; severance includes 12 months base salary."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-001296","json":"https://secwatch.observer/filing/0001493152-23-001296.json","markdown":"https://secwatch.observer/filing/0001493152-23-001296.md","text":"https://secwatch.observer/filing/0001493152-23-001296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223001296/0001493152-23-001296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223001296/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T15:57:52.216607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}